A detailed history of Money Concepts Capital Corp transactions in Biogen Inc. stock. As of the latest transaction made, Money Concepts Capital Corp holds 8,884 shares of BIIB stock, worth $1.74 Million. This represents 0.19% of its overall portfolio holdings.

Number of Shares
8,884
Previous 9,095 2.32%
Holding current value
$1.74 Million
Previous $1.96 Million 5.0%
% of portfolio
0.19%
Previous 0.19%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 02, 2024

SELL
$190.52 - $236.72 $40,199 - $49,947
-211 Reduced 2.32%
8,884 $2.06 Million
Q1 2024

May 01, 2024

SELL
$212.02 - $267.71 $25,230 - $31,857
-119 Reduced 1.29%
9,095 $1.96 Million
Q4 2023

Feb 12, 2024

SELL
$222.59 - $267.94 $51,640 - $62,162
-232 Reduced 2.46%
9,214 $2.38 Million
Q3 2023

Oct 31, 2023

BUY
$253.3 - $285.89 $94,480 - $106,636
373 Added 4.11%
9,446 $2.43 Million
Q2 2023

Jul 31, 2023

BUY
$275.25 - $318.06 $74,868 - $86,512
272 Added 3.09%
9,073 $2.58 Million
Q1 2023

May 01, 2023

SELL
$256.56 - $292.34 $680,140 - $774,993
-2,651 Reduced 23.15%
8,801 $2.45 Million
Q4 2022

Feb 14, 2023

BUY
$252.44 - $306.72 $192,106 - $233,413
761 Added 7.12%
11,452 $3.17 Million
Q3 2022

Oct 27, 2022

SELL
$194.69 - $268.46 $82,353 - $113,558
-423 Reduced 3.81%
10,691 $2.85 Million
Q2 2022

Jul 18, 2022

SELL
$187.54 - $223.02 $224,485 - $266,954
-1,197 Reduced 9.72%
11,114 $2.34 Million
Q1 2022

May 13, 2022

BUY
$193.77 - $244.14 $502,639 - $633,299
2,594 Added 26.7%
12,311 $2.59 Million
Q4 2021

Feb 14, 2022

BUY
$223.92 - $287.77 $300,724 - $386,475
1,343 Added 16.04%
9,717 $2.33 Million
Q1 2021

May 17, 2021

BUY
$242.95 - $284.63 $1.07 Million - $1.26 Million
4,413 Added 111.41%
8,374 $2.34 Million
Q4 2020

May 17, 2021

BUY
$236.26 - $355.63 $935,825 - $1.41 Million
3,961 New
3,961 $970,000

Others Institutions Holding BIIB

About BIOGEN INC.


  • Ticker BIIB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 144,000,992
  • Market Cap $28.2B
  • Description
  • Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...
More about BIIB
Track This Portfolio

Track Money Concepts Capital Corp Portfolio

Follow Money Concepts Capital Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Money Concepts Capital Corp, based on Form 13F filings with the SEC.

News

Stay updated on Money Concepts Capital Corp with notifications on news.